Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19

Recent advances in the pathophysiologic understanding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has indicated that patients with severe coronavirus disease 2019 (COVID-19) might experience cytokine release syndrome (CRS), characterized by increased interleukin (IL...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Wei, Li, Yi-Xin, Jiang, Li-Jun, Chen, Qian, Wang, Tao, Ye, Da-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298494/
https://www.ncbi.nlm.nih.gov/pubmed/32580895
http://dx.doi.org/10.1016/j.tips.2020.06.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298494/
https://www.ncbi.nlm.nih.gov/pubmed/32580895
http://dx.doi.org/10.1016/j.tips.2020.06.007

Ejemplares similares